Thromboelastographic study of biomaterials

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 94, Issue 2, 2010, Pages 469-485

  Peng, Henry T ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Biomaterials; Blood coagulation; Blood compatibility; Hemorrhage control; Thromboelastography

Indexed keywords

BIOMEDICAL DEVICES; BLOOD COAGULATION; BLOOD COMPATIBILITY; BLOOD COMPONENT; CLINICAL TRIAL; CLOT FORMATION; COAGULATION PROCESS; FUTURE DIRECTIONS; HEMORRHAGE CONTROL; IN-VITRO; IN-VIVO; RELATIVE CONTRIBUTION; WHOLE BLOOD;

BIOLOGICAL MATERIALS; BLOOD SUBSTITUTES; COAGULATION; FUNCTIONAL POLYMERS; THERMOELECTRIC EQUIPMENT;

BLOOD;

BIOMATERIAL; BIOPOLYMER; BLOOD CLOTTING FACTOR; CHITOSAN; DACRON; FIBRINOGEN; POLITEF;

BIOMEDICINE; BLOOD CLOTTING; BLOOD COMPATIBILITY; CERAMICS; EXTRACORPOREAL CIRCULATION; FIBRINOLYSIS; HEART ASSIST DEVICE; HYDROGEL; REVIEW; THROMBOCYTE; THROMBOELASTOGRAPHY; DEVICES; DRUG EFFECTS; HUMAN; PROCEDURES; STANDARDS;

BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; EQUIPMENT AND SUPPLIES; HUMANS; THROMBELASTOGRAPHY;

EID: 77955373022     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31626     Document Type: Review

References (124)

1. Hanson S, Harker L. Blood coagulation and blood-materials interactions. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials Science: An Introduction to Materials in Medicine. San Diego: Academic Press; 1996. pp 193-199.
2. Courtney J, Lamba N, Sundaram S, Forbes C. Biomaterials for blood-contacting applications. Biomaterials 1994;15:737-744.
3. Banerjee R, Nageswari K, Puniyani RR. Hemotological aspects of biocompatibility-review article. J Biomater Appl 1997;12:57-76.
4. Neuffer MC, McDivitt J, Rose D, King K, Cioonan CC, Vayer JS. Hemostatic dressings for the first responder: A review. Mil Med 2004;169:716-720. (Pubitemid 40797241)
5. Waner M. Novel hemostatic alternatives in reconstructive surgery. Semin Hematol 2004;41 (Suppl 1):163-167. (Pubitemid 38182733)
6. Linkins L-A, Weitz JI. New anticoagulant therapy. Ann Rev Med 2005;56:63-77.
7. Michanetzis GPA, Missirlis YF. Influence of test protocol in determining the blood response to model polymers. J Mater Sci Mater Med 2002;13:757-765.
8. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001;12:327-337.
9. Vig S, Chitolie A, Bevan DH, Halliday A, Dormandy J. Thromboelastography: A reliable test? Blood Coagul Fibrinolysis 2001;12: 555-561.
10. Donahue SM, Otto CM. Thromboelastography: A tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Veterinary Emerg Crit Care 2005;15:9-16.
11. Greaves M. Assessment of haemostasis. Vox Sang 2004;87: S47-S50.
12. Holt AW, Bierer P, Glover P, Plummer JL, Bersten AD. Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits. Intensive Care Med 2002;28:1649-1655. (Pubitemid 36002517)
13. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haem 2005;27:81-90.
14. Westbrook AJ, Olsen J, Bailey M, Bates J, Scully M, Salamonsen RF. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: A pilot study. Heart Lung Circulat 2009;18:277-288.
15. Carr ME, Jr., Martin EJ, Kuhn JG, Ambrose H, Fern S, Bryant PC. Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa. Clin Lab 2004;50:529-538. (Pubitemid 39307362)
16. Lang T, Toller W, Gutl M, Mahla E, Metzler H, Rehak P, Marz W, Halwachs-Baumann G. Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004;2:147-153. (Pubitemid 40185631)
17. Kawasaki J, Katori N, Taketomi T, Terui K, Tanaka KA. The effects of vasoactive agents, platelet agonists and anticoagulation on thrombelastography. Acta Anaesthesiol Scand 2007;51: 1237-1244. (Pubitemid 47389697)
18. Kawaguchi C, Takahashi Y, Hanesaka Y, Yoshioka A. The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram. Thromb Haemost 2002;88:768-772. (Pubitemid 35345334)
19. Landskroner KA, Colson NC, Jesmok GJ. Thromboelastography measurements of whole blood from factor VIII-deficient mice supplemented with rFVIII. Haemophilia 2005;11:346-352.
20. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: The role of fibrinogen administration. Anesth Analg 2007;105:905-917. (Pubitemid 47479300)
21. Kannan RY, Salacinski HJ, De Groot J, Clatworthy I, Bozec L, Horton M, Butler PE, Seifalian AM. The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. Biomacromolecules 2006;7:215-223. (Pubitemid 43154497)
22. Hall B, Bird R, Chapman D. Phospholipid polymers and new haemocompatible materials. Angew Makromol Chem 1989;166/167: 169-178.
23. Bird RR, Hall B, Chapman D, Hobbs KE. Material thrombelastography: An assessment of phosphorylcholine compounds as models for biomaterials. Thromb Res 1988;51:471-483.
24. Lang T, Bauters A, Braun S, Potzsch B, von Pape K, Kolde H. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005;16:301-310. (Pubitemid 40705054)
25. Nielsen V. A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007;18:247-252.
26. Mortier E, Ongenae M, De Baerdemaeker L, Herregods L, Den Blauwen N, Van Aken J, Rolly G. In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography. Anaesthesia 1997;52:1061-1064.
27. Karoutsos S, Nathan N, Lahrimi A, Grouille D, Feiss P, Cox DJA. Thrombelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 1999;82:175-177. (Pubitemid 29057611)
28. Petroianu GA, Liu J, Maleck WH, Mattinger C, Bergler WF. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph. Anesth Analg 2000;90:795-800. (Pubitemid 30190780)
29. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001;15:316-321.
30. Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The Influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001;92:565-571.
31. Fries D, Innerhofer P, Klingler A, Berresheim U, Mittermayr M, Calatzis A, Schobersberger W. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: An in vitro study using Thrombelastograph® Coagulation Analysis (ROTEG®). Anesth Analg 2002;94:1280-1287.
32. Roche AM, James MFM, Grocott MPW, Mythen MG. Coagulation effects of in vitro serial haemodilution with a balanced electrolyte hetastarch solution compared with a saline-based hetastarch solution and lactated Ringer's solution. Anaesthesia 2002;57:950-955.
33. Jones SB, Whitten CW, Despotis GJ, Monk TG. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: A preliminary survey of hemostatic markers. Anesth Analg 2003;96:363-368.
34. Fenger-Eriksen C, Anker-Møller E, Heslop J, Ingerslev J, Sørensen B. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: Improvements of the induced coagulopathywith fibrinogen concentrate. Br J Anaesth 2005;94:324-329.
35. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005;49:373-378.
36. Shamash Y, Alexander B. Coagulation studies with linear copolymers of aliphatic hydrocarbons and maleic acid: New class of anticoagulants. Biochim Biophys Acta 1969;194:449-461.
37. Marchisio MA, Sbertoli C, Farina G, Ferruti P. A new antagonist of heparin: Partially N-oxidized poly-allyldiethylamine. Eur J Pharmacol 1970;12:236-242.
38. Kopeîcek J, îSpprincl L, Lǐm D. New types of synthetic infusion solutions. I. Investigation of the effect of solutions of some hydrophilic polymers on blood. J Biomed Mater Res 1973;7: 179-191.
39. Lee D-W, Baney R. Oligochitosan derivatives bearing electron-deficient aromatic rings for adsorption of amitriptyline: Implications for drug detoxification. Biomacromolecules 2004;5: 1310-1315.
40. Kainthan RK, Hester SR, Levin E, Devine DV, Brooks DE. In vitro biological evaluation of high molecular weight hyperbranched polyglycerols. Biomaterials 2007;28:4581-4590.
41. Rossi NAA, Mustafa I, Jackson JK, Burt HM, Horte SA, Scott MD, Kizhakkedathu JN. In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators. Biomaterials 2009;30:638-648.
42. Senzolo M, Coppell J, Cholongitas E, Riddell A, Triantos CK, Perry D, Burroughs AK. The effects of glycosaminoglycans on coagulation: A thromboelastographic study. Blood Coagul Fibrinolysis 2007;18:227-236.
43. Kidane AG, Salacinski HJ, Punshon G, Ramesh B, Srai KS, Seifalian AM. Synthesis and evaluation of amphiphilic RGD derivatives: Uses for solvent casting in polymers and tissue engineering applications. Med Biol Eng Comput 2003;41: 740-745.
44. Smith SA, Morrissey JH. Polyphosphate as a general procoagulant agent. J Thromb Haemost 2008;6:1750-1756.
45. Prasad S, Lillicrap D, Labelle A, Knappe S, Keller T, Burnett E, Powell S, Johnson KW. Efficacy and safety of a new-class hemostatic drug candidate. AV513, in dogs with hemophilia A. Blood 2008;111:672-679.
46. Chepurov AK, Belomestnaia ZM, Donetskii IA, Tsidvintseva GV. Thromboresistent properties of hydrophilic gels. Biull Eksp Biol Med 1980;89:289-292.
47. Hall B, Bird RR, Kojima M, Chapman D. Biomembranes as models for polymer surfaces. V. Thrombelastographic studies of polymeric lipids and polyesters. Biomaterials 1989;10:219-224.
48. Klocking HP, Schunk W, Merkmann G, Giessmann C, Knoll H, Borgmann S. A natural rubber drainage tube with antithrombogenic lumen surface. Thromb Res 1993;72:501-507.
49. Lee D-W, Powers K, Baney R. Physicochemical properties and blood compatibility of acylated chitosan nanoparticles. Carbohydr Polym 2004;58:371-377.
50. Morey TE, Varshney M, Flint JA, Seubert CN, Smith WB, Bjoraker DG, Shah DO, Dennis DM. Activity of microemulsion-based nanoparticles at the human bio-nano interface: Concentration-dependent effects on thrombosis and hemolysis in whole blood. J Nanopart Res 2004;6:159-170.
51. Valeri CR, Srey R, Tilahun D, Ragno G. In vitro effects of poly-Nacetyl glucosamine on the activation of platelets in platelet-rich plasma with and without red blood cells. J Trauma 2004;57: S22-S25.
52. Murugesan S, Mousa S, Vijayaraghavan A, Ajayan PM, Linhardt RJ. Ionic liquid-derived blood-compatible composite membranes for kidney dialysis. J Biomed Mater Res B Appl Biomater 2006; 79:298-304.
53. Fischer T, Bode A, Demcheva M, Vournakis J. Hemostatic properties of glucosamine-based materials. J Biomed Mater Res A 2007;80:167-174.
54. Boccafoschi F, Habermehl J, Vesentini S, Mantovani D. Biological performances of collagen-based scaffolds for vascular tissue engineering. Biomaterials 2005;26:7410-7417.
55. Peng HT, Blostein MD, Shek PN. Experimental optimization of an in situ forming hydrogel for hemorrhage control. J Biomed Mater Res Part B: Appl Biomater 2009;89:199-209.
56. Peng HT, Shek PN. Development of in situ-forming hydrogels for hemorrhage control. J Mater Sci Mater Med 2009;20:1753-1762.
57. Marchandy C, Rivardz G-E, Sunx J, Hoemannyk CD. Solidification mechanisms of chitosaneglycerol phosphate/blood implant for articular cartilage repair. Osteoarthritis Cartil 2009;17: 953-960.
58. Ostomel T, Stoimenov P, Holden P, Alam H, Stucky G. Hostguest composites for induced hemostasis and therapeutic healing in traumatic injuries. J Thromb Thrombolysis 2006;22:55-67.
59. Ostomel T, Shi Q, Tsung C-K, Liang H, Stucky G. Spherical bioactive glass with enhanced rates of hydroxyapatite deposition and hemostatic activity. Small 2006;2:1261-1265.
60. Ostomel T, Shi Q, Stucky G. Oxide hemostatic activity. J Am Chem Soc 2006;128:8384-8385.
61. Ostomel TA, Shi Q, Stoimenov PK, Stucky GD. Metal oxide surface charge mediated hemostasis. Langmuir 2007;23: 11233-11238.
62. Bolz A, Schaldach M. Haemocompatibility optimisation of implants by hybrid structuring. Med Biol Eng Comput 1993;31 (Suppl):S123-S130.
63. Murugesan S, Park TJ, Yang H, Mousa S, Linhardt RJ. Blood compatible carbon nanotubes-nano-based neoproteoglycans. Langmuir 2006;22:3461-3463.
64. Jovanovic AV, Flint JA, Varshney M, Morey TE, Dennis DM, Duran RS. Surface modification of silica core-shell nanocapsules: Biomedical implications. Biomacromolecules 2006;7:945-949.
65. Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer H, Krenn CG, Unger S, Hetz H. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: An observational study. Crit Care 2006;10:R24.
66. Kirshbom PM, Miller BE, Spitzer K, Easley KA, Spainhour CE, Kogon BE, Kanter KR. Failure of surface-modified bypass circuits to improve platelet function during pediatric cardiac surgery. J Thorac Cardiovasc Surg 2006;132:675-680.
67. Bonaros N, Mueller M-R, Salat A, Schima H, Roethy W, Rocher AA, Wolner E, Wieselthaler GM. Extensive coagulation monitoring in patients after implantation of the MicroMed Debakey continuous flow axial pump. ASAIO J 2004;50:424-431.
68. Zambruni A, Thalheimer U, Leandro G, Perry D, Burroughs AK. Thromboelastography with citrated blood: Comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004;15:103-107.
69. Orlikowski CEP, Murray WB, Rocke DA. Effect of delay and storage on whole-blood clotting analysis as determined by thrombelastography. J Clin Monit 1993;9:5-8.
70. Katori N, Tanaka KA, Szlam F, Levy JH. The effects of platelet count on clot retraction and tissue plasminogen activatorinduced fibrinolysis on thrombelastography. Anesth Analg 2005; 100:1781-1785.
71. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography®: Critical roles of fibrinogen and factors II. VII, X and XII. Acta Anaesthesiol Scand 2005;49:222-231.
72. Avidan M, Da F, Parmar K, Alcock E, Ponte J, Hunt B. The effects of aprotinin on thromboelastography with three different activators. Anesthesiology 2001;95:1169-1174.
73. Haemoscope Corporation. TEG® 5000 User's Manual 2004. Haemoscope Corporation, Niles, IL, USA. pp. 149-161.
74. Romlin B, Petruson K, Nilsson K. Moderate superficial hypothermia prolongs bleeding time in humans. Acta Anaesthesiol Scand 2007;51:198-201.
75. Felfernig M, Kubricht V, Zimpfer M, Kozek S, Hoerauf K, Blaicher AM. Hypothermia and hyperthermia decrease the anticoagulant potency of low molecular weight heparin measured with thrombelastgraphy. Eur Surg 2006;38:213-216.
76. Camenzind V, Bombeli T, Seifert B, Jamnicki M, Popovic D. Citrate storage affects thrombelastography analysis. Anesthesiology 2000;92:1242-1249.
77. Zdrahala R, Zdrahala I. Biomedical applications of polyurethanes: A review of past, promises, present realities, and a vibrant future. J Biomater Appl 1999;14:67-90.
78. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: A comparative review. Crit Care Med 2001;29: 1261-1267.
79. Madjdpour C, Dettori N, Frascarolo P, Burki M, Boll M, Fisch A, Bombeli T, Spahn DR. Molecular weight of hydroxyethyl starch: Is there an effect on blood coagulation and pharmacokinetics? Br J Anaesth 2005;94:569-576.
80. von Roten I, Madjdpour C, Frascarolo P, Burmeister M-A, Fisch A, Schramm S, Bombeli T, Spahn DR. Molar substitution and C2/C6 ratio of hydroxyethyl starch: Influence on blood coagulation. Br J Anaesth 2006;96:455-463.
81. Nielsen VG, Baird MS. Extreme hemodilution in rabbits: An in vitro and in vivo thrombelastographic analysis. Anesth Analg 2000;90:541-545.
82. Ikada Y. Blood-compatible polymers. Adv Polym Sci 1984;57: 103-140.
83. Bird RL, Hall B, Hobbs KE, Chapman D. New haemocompatible polymers assessed by thrombelastography. J Biomed Eng 1989; 11:231-234.
84. Viswanathan G, Murugesan S, Pushparaj V, Nalamasu O, Ajayan PM, Linhardt RJ. Preparation of biopolymer fibers by electrospinning from room temperature ionic liquids. Biomacromolecules 2006;7:415-418.
85. McNulty SE, Maguire DP, Thomas RE. Effect of heparin-bonded pulmonary artery catheters on the activated coagulation time. J Cardiothorac Vasc Anesth 1998;12:533-535.
86. Weiss BM, Von Segesser LK, Turina MI, Seifert B, Pasch T. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: Low-dose versus high-dose heparin management. J Cardiothorac Vasc Anesth 1996;10:464-470.
87. Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999;16:342-350.
88. Farndale RW, Sixma JJ, Barnes MJ, De Groot PG. The role of collagen in thrombosis and hemostasis. J Thromb Haemostasis 2004;2:561-573.
89. Kawamoto Y, Kaibara M. Procoagulant activity of collagen. Effect of difference in type and structure of collagen. Biochim Biophys Acta 1990;1035:361-368.
90. Gutowska A, Jeong B, Jasionowski M. Injectable gels for tissue engineering. Anat Rec 2001;263:342-349.
91. Kretlow JD, Klouda L, Mikos AG. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:263-273.
92. Silver F, Wang MC, Pins GD. Preparation and use of fibrin glue in surgery. Biomaterials 1995;16:891-903.
93. Bennett S, Melanson D, Torchiana D, Wiseman D, Sawhney A. Next-generation hydrogel films as tissue sealants and adhesion barriers. J Cardiovasc Surg 2003;18:494-499.
94. Glidden P, Malaska C, Herring S. Thromboelastograph assay for measuring the mechanical strength of fibrin sealant clots. Clin Appl Thromb Hemost 2000;6:226-233.
95. Lewis KB, Jr., Brown PA, Lasser GW, Bishop PD. Tissue sealant compositions. US Pat. No. 6,780,411 (2004).
96. Gennisson J-L, Lerouge S, Cloutier G. Assessment by transient elastography of the viscoelastic properties of blood during clotting. Ultrasound Med Biol 2006;32:1529-1537.
97. Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000;21:2155-2161.
98. Ruel-Gariépy E, Shive M, Bichara A, Berrada M, Le Garrec D, Chenite A, Leroux J-C. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 2004;57:53-63.
99. Thamaraiselvi TV, Rajeswari S. Biological evaluation of bioceramic materials - A review. Trends Biomater Artif Organs 2004;18:9-17.
100. Bolz A, Schaldach M. Artificial heart valves: Improved blood compatibility by PECVD a-SiC:H coating. Artif Organs 1990;14: 260-269.
101. Hansi C, Arab A, Rzany A, Ahrens I, Bode C, Hehrlein C. Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces. Catheter Cardiovasc Interv 2009;73:488-496.
102. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan RR, Read RA, Pons PT. Epidemiology of trauma deaths: A reassessment. J Trauma 1995;38:185-193.
103. Champion H, Bellamy R, Roberts C, Leppaniemi A. A profile of combat injury. J Trauma 2003;54:S13-S19.
104. Kozen BG, Kircher SJ, Henao J, Godinez FS, Johnson AS. An alternative hemostatic dressing: Comparison of CELOX. HemCon, and QuikClot. Acad Emerg Med 2008;15:74-81.
105. Pusateri AE, Delgado AV, Dick EJ, Jr., Martinez RS, Holcomb JB, Ryan KL. Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine. J Trauma 2004;57:555-562.
106. Alam HB, Chen Z, Jaskille A, Querol RILC, Koustova E, Inocencio R, Conran R, Seufert A, Ariaban N, Toruno K, Rhee P. Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in swine. J Trauma 2004;56: 974-983.
107. Kheirabadi BS, Edens JW, Terrazas IB, Estep JS, Klemcke HG, Dubick MA, Holcomb JB. Comparison of new hemostatic granules/ powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine. J Trauma 2009;66:316-328.
108. Rabea EI, Badawy ME-T, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 2003;4:1457-1465.
109. Okamotoa Y, Yanoa R, Miyatakea K, Tomohirob I, Shigemasac Y, Minami S. Effects of chitin and chitosan on blood coagulation. Carbohydr Polym 2003;53:337-342.
110. Rao SB, Sharma CP. Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential. J Biomed Mater Res 1997;34:21-28.
111. Whang HS, Kirsch W, Zhu YH, Yang CZ, Hudson SM. Hemostatic agents derived from chitin and chitosan. J Macromol Sci Part C: Polym Rev 2005;45:309-323.
112. Bergera J, Reista M, Mayera JM, Feltb O, Peppasc NA, Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 2004;57:19-34. (Pubitemid 38058801)
113. Ono K, Saito Y, Yura H, Ishikawa K, Kurita A, Akaike T, Ishihara M. Photocrosslinkable chitosan as a biological adhesive. J Biomed Mater Res 2000;49:289-295.
114. Shepherd R, Reader S, Falshaw A. Chitosan functional properties Glycoconjugate J 1997;14:535-542.
115. Shimojoh M, Fukushima K, Kurita K. Low-molecular-weight chitosans derived from β-chitin: Preparation, molecular characteristics and aggregation activity. Carbohydr Polym 1998;35:223-231.
116. Kamaraj J, Swaminathan E, Dharmalingam S. Development and characterization of polymer ceramic composites for orthopedic applications. Trends Biomater Artif Organs 2009;22:165-174.
117. Tan HK. Molecular adsorbent recirculating system (MARS). Ann Acad Med Singapore 2004;33:329-335.
118. Ramström S. Clotting time analysis of citrated blood samples is strongly affected by the tube used for blood sampling. Blood Coagul Fibrinolysis 2005;16:447-452.
119. Bowbrick VA, Mikhailidis DP, Stansby GM. The use of citrated whole blood in thromboelastography. Anesth Analg 2000;90: 1086-1088.
120. Samama C, Ozier Y. Near-patient testing of haemostasis in the operating theatre: An approach to appropriate use of blood in surgery. Vox Sang 2003;84:251-255.
121. Srinivasa V, Gilbertson L, Bhavani-Shankar K. Thromboelastography: Where is it and where is it heading? Int Anesthesiol Clin 2001;39:35-49.
122. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003;1: 551-558.
123. McNulty SE, Maguire DP, Arai LD. An alternate method for calibrating the thrombelastograph. J Cardiothorac Vasc Anesth 1998;12:639-641.
124. Lomas-Niera JL, Perl M, Chung C-S, Ayala A. Shock and hemorrhage: An overview of animal models. Shock 2005;24 Suppl: 33-39.